Toxikon is a prominent supplier to the pharmaceutical industry, specialising in a wide array of services that cater to the needs of drug development and research. The company offers a comprehensive range of solutions designed to support various stages of pharmaceutical research, ensuring compliance with regulatory standards and optimising product efficacy and safety. With a commitment to scientific excellence, Toxikon aids clients in navigating the complexities of drug development processes.

Services include:
– Accelerated Stability Studies
– ADMET
– Analytical Services
– Assay Development
– Bioanalytical Services
– Biological Testing
– Cell Culture Media Development
– Chemical Analysis
– Chromatography
– Contaminant Analysis
– Contract Research (CRO)
– Custom Manufacturing
– Drug Development
– Contract Development
– Efficacy Testing
– Testing
– Process Development
– Formulation Development
– Immunobiology Services
– Immunotoxicity Testing
– In Vitro Testing
– IND/NDA Submissions
– Mass Spectrometry
– Materials Analysis
– Metabolic Analysis
– Microbiological Testing
– Pharmacokinetics
– Pharmacology
– Photostability
– Preclinical Study Design
– Preclinical Testing
– Preclinical Testing Formulations
– Quality QA/QC
– R&D Services
– Radiopharmaceuticals
– Raw Materials Analysis
– Stability Studies
– Stability
– ICH
– Sterility Testing
– Toxicology Services & Analysis
– Trace Metal Analysis
– ICP
– UV-VIS Spectrophotometer Analysis
– Wet Chemical Analysis

Toxikon remains a pivotal player in the pharmaceutical supply sector, offering invaluable support to clients aiming to bring safe and effective products to market. For more information, please visit toxikon.com.